Retrorectal Tumor: Is Biopsy Risky?
A 55-year-old white man with an extensive retrorectal tumor died after transrectal needle biopsy. The indications and methods for biopsy of tumors in this location are controversial and are not well delineated in the literature. When resection seems unlikely or risky, or if a neoplasm is suspected which could be treated by nonsurgical means, biopsy is indicated. Antibiotics with aerobic and anaerobic coverage should be given prophylactically. When CT scan or sigmoidoscopic findings suggest a necrotic tumor, the transrectal approach should be avoided.
Published In/Presented At
Verazin, G., Rosen, L., Khubchandani, I. T., Sheets, J. A., Stasik, J. J., & Riether, R. (1986). Retrorectal tumor: is biopsy risky?. Southern Medical Journal, 79(11), 1437-1439.
Other Medical Specialties | Surgery
Department of Surgery, Department of Surgery Faculty